Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
J Diabetes Investig. 2020 Sep;11(5):1370-1373. doi: 10.1111/jdi.13266. Epub 2020 May 6.
A 38-year-old woman with type 1 diabetes, whose fasting plasma glucose levels were >500 mg/dL under 176 U/day of subcutaneous insulin injection, was admitted to Nippon Medical School Hospital, Tokyo, Japan. When insulin was administered intravenously, she was able to maintain favorable glycemic control even under 24 U/day of regular insulin, showing that she was accompanied by subcutaneous insulin resistance. To choose an optimal insulin regimen, we carried out subcutaneous insulin challenge tests without or with heparin mixture, and found a cocktail of insulin lispro and heparin could reduce blood glucose levels markedly. As a consequence, she achieved favorable blood glucose control by continuous subcutaneous insulin infusion of the cocktail. In summary, the insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in cases of subcutaneous insulin resistance.
一位 38 岁的 1 型糖尿病女性患者,每天接受 176U 以下的皮下胰岛素注射时,空腹血糖水平>500mg/dL,因血糖控制不佳入住在日本东京的日本医科大学医院。静脉内给予胰岛素时,她每天仅需 24U 的常规胰岛素就能维持良好的血糖控制,这表明她同时存在皮下胰岛素抵抗。为了选择最佳的胰岛素治疗方案,我们进行了无肝素或肝素混合的皮下胰岛素挑战试验,发现胰岛素赖脯氨酸和肝素的混合物可显著降低血糖水平。因此,她通过持续皮下输注这种混合物实现了良好的血糖控制。总之,胰岛素和肝素挑战试验有助于选择皮下胰岛素抵抗患者的最佳胰岛素治疗方案。